ADME Toxicology Testing Market Growth To $20.25 Billion By 2030: What’s Driving The Expansion?
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
ADME Toxicology Testing Market Forecast: Value Set To Climb From $12.83 Billion To $20.25 Billion
The adme toxicology testing market size has shown substantial growth in recent years. It is forecast to increase from $11.5 billion in 2025 to $12.83 billion in 2026, registering a compound annual growth rate (CAGR) of 11.6%. This historical growth can be attributed to factors like the limited availability of automated adme testing systems, reliance on traditional biochemical assays, a rising regulatory focus on drug safety, expanding pharmaceutical research initiatives, and the adoption of LC-MS and HPLC instruments.
The adme toxicology testing market is projected to experience swift expansion in the coming years. It is anticipated to reach $20.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.1%. This expansion during the projection period stems from factors such as the creation of integrated adme platforms, the growing use of omics and molecular imaging technologies, increased financial commitment to predictive toxicology software, the broader application of adme testing within the cosmetics and food sectors, and the implementation of AI-powered risk assessment tools. Key trends expected over the forecast horizon encompass the increasing uptake of high-throughput screening instruments, a greater reliance on cell-based and in vitro assays, an escalating need for omics-based toxicology methods, the broader incorporation of adme testing into pharmaceutical development, and the merging of simulation and modeling software into risk assessment processes.
Get A Free Sample Report With In-Depth Market Insights:
ADME Toxicology Testing Market Industry Drivers: What’s Behind The Revenue Growth?
An increasing need for novel drugs is projected to fuel expansion in the ADME toxicology testing market. Novel drugs are pharmaceutical substances that have not been previously approved or marketed for therapeutic use. ADME toxicity testing constitutes a vital stage in drug creation, guaranteeing that these novel drugs are safe and do not generate harmful toxins within the body. For example, in January 2024, the Center for Drug Evaluation and Research (CDER), a US-based branch of the U.S. Food and Drug Administration (FDA), reported in its New Drug Therapy Approvals 2023 report that it approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, compared to 37 novel drug approvals in 2022. Consequently, the rising demand for novel drugs is driving the growth of the ADME toxicology testing market.
ADME Toxicology Testing Market Segment Analysis: What Are The Core Market Categories?
The adme toxicology testing market covered in this report is segmented –
1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types
2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo
3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies
4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications
5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users
Subsegments:
1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations
2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software
3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays
4) By Reagents: Biochemicals, Buffer Solutions, Culture Media
5) By Other Products: Kits And Consumables, Analytical Standards
#ADME Toxicology Testing Market Growth Trends: What’s Shaping The Future Outlook?
Major companies operating in the ADME toxicology testing market are adopting advanced technologies, such as the Cyprotex e-Store, for the online procurement of ADME-Tox services. The goal of ADME-Tox services is to reduce development expenditures and time, diminish the likelihood of failures occurring at a subsequent stage, and enable the selection of the most suitable candidate for clinical development. For instance, in October 2023, Evotec SE, a biotechnology firm from Germany, introduced the Cyprotex e-Store, an e-commerce platform designed to offer straightforward online access to the company’s extensive suite of ADME-Tox services. This e-Store simplifies and accelerates the buying journey, permitting registered users to evaluate and order Cyprotex’ offerings continuously, seven days a week. It provides immediate online access to pricing and comprehensive protocols, allowing users to effortlessly place orders, monitor their status, and reorder when necessary. This efficient platform reduces the service lead time, enabling users to obtain their data faster.
ADME Toxicology Testing Market Top Companies Driving Competitive Growth
Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.
View The Full ADME Toxicology Testing Market Report:
ADME Toxicology Testing Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
